Crown Holdings
CCK
$101.54
-0.41%
Crown Holdings Inc. is a leading global producer of metal packaging, primarily manufacturing beverage cans, metal food cans, and closures, with a significant presence in protective transport packaging following its acquisition of Signode. The company operates in the packaging and containers industry, serving a global customer base with the vast majority of its sales derived from Europe, South America, and Southeast Asia. The current investor narrative centers on the stock's defensive characteristics amidst economic uncertainty, with recent news highlighting its strong cash flow generation and recent dividend increase as key attractions for yield-seeking investors in a higher interest rate environment. This positions Crown as a beneficiary of investor rotation into stable, cash-generative businesses with inflation-resistant pricing power.…
CCK
Crown Holdings
$101.54
Related headlines
Investment Opinion: Should I buy CCK Today?
Rating: Hold. The core thesis is that CCK offers deep value and defensive cash flow, but these are currently counterbalanced by severe margin erosion and negative price momentum, warranting a neutral stance until clarity emerges.
Supporting evidence includes a forward P/E of 10.76x, which is low for a company with a 24.47% ROE, and substantial TTM free cash flow of $1.10B. The stock trades at a Price-to-Sales ratio of 0.96x, suggesting it is not expensive on a revenue basis. The implied analyst target of $102.22 offers a modest 7.5% upside, but this is contingent on an earnings recovery to an estimated $9.50 EPS. The current price is just 5.9% above the 52-week low, indicating most bad news may be priced in.
The thesis would upgrade to Buy if Q1 2026 gross margins recover sustainably above 18%, confirming the Q4 plunge was an anomaly, or if the price breaks and holds above $105 on strong volume, signaling technical repair. It would downgrade to Sell if gross margins remain below 12% for another quarter or if the stock breaks below the $89.21 support level. Relative to its own history and sector, the stock appears fairly valued to slightly undervalued, but the valuation discount is justified by the elevated operational risk.
Sign up to view all
CCK 12-Month Price Forecast
The outlook is clouded by the unresolved gross margin collapse, making near-term predictions highly uncertain. The strong cash flow and low valuation provide a margin of safety, but the technical breakdown and fundamental deterioration cannot be ignored. The base case of a grinding, range-bound recovery is most likely, as the company works through its cost issues. The stance would upgrade to Bullish on confirmation of margin recovery in the next quarterly report, supported by a move above the 200-day moving average. It would downgrade to Bearish on a confirmed breakdown below $89.21 with no improvement in profitability metrics.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Crown Holdings's 12-month outlook, with a consensus price target around $132.00 and implied upside of +30.0% versus the current price.
Average Target
$132.00
7 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
7
covering this stock
Price Range
$81 - $132
Analyst target range
Analyst coverage for Crown Holdings is limited, with only 7 analysts providing estimates, indicating it is a mid-cap name with moderate institutional following. The consensus appears mixed, with recent actions including a downgrade from JP Morgan to 'Neutral' from 'Overweight' in February 2026, while firms like RBC Capital, Truist Securities, and Mizuho maintain 'Outperform' or 'Buy' ratings. The average target price implied by the estimated EPS of $9.50 and the forward P/E of 10.76x is approximately $102.22, suggesting an implied upside of roughly 7.5% from the current price of $95.08. The target range is relatively tight, with EPS estimates spanning from $8.74 to $10.51. The high-end target likely assumes a successful recovery in gross margins and stable demand, while the low-end may be factoring in continued cost pressures or a deeper economic slowdown. The limited number of analysts and the recent downgrade signal some caution, but the maintained bullish ratings from several firms suggest a belief in the company's long-term fundamentals and defensive cash flow profile.
Bulls vs Bears: CCK Investment Factors
The evidence currently tilts bearish, primarily due to the severe and unexplained collapse in gross margins and the stock's pronounced technical breakdown. The bull case rests on attractive valuation, strong cash flow, and defensive characteristics, but these are being overshadowed by fundamental deterioration. The single most important tension in the investment debate is whether the Q4 gross margin plunge to 10.3% is a temporary anomaly or a sign of a permanent structural decline in profitability. The resolution of this margin question will determine if the stock's deep value is a trap or an opportunity.
Bullish
- Strong Free Cash Flow Generation: The company generated $1.10 billion in TTM free cash flow and $236 million in the latest quarter, providing significant financial flexibility. This robust cash generation supports the recent dividend increase and underpins the defensive investment narrative in a high-rate environment.
- Attractive Forward Valuation: With a forward P/E of 10.76x based on estimated EPS of $9.50, the stock trades at a 33% discount to its trailing P/E of 16.16x. This low multiple suggests the market has priced in significant pessimism, offering a margin of safety if earnings recover.
- High Return on Equity: The company's ROE stands at a strong 24.47%, indicating efficient use of shareholder capital. While amplified by leverage, this level of profitability is attractive for a mature industrial business.
- Defensive Business Model: As a producer of essential metal packaging, Crown's business is relatively non-cyclical. This defensive characteristic is appealing during economic uncertainty, as evidenced by investor rotation into such stocks noted in recent news.
Bearish
- Severe Gross Margin Compression: Q4 2025 gross margin collapsed to 10.3%, down sharply from 22.6% in Q2 2025 and 22.4% in Q4 2024. This dramatic volatility signals acute pressure from input costs, mix shifts, or pricing, directly threatening profitability.
- Pronounced Technical Downtrend: The stock is down 17.03% over the last three months and trades near its 52-week low of $89.21, showing severe negative momentum. Its relative strength of -27.31 vs. the S&P 500 over 3 months indicates intense selling pressure and a lack of catalysts.
- High Financial Leverage: The debt-to-equity ratio of 2.06 is elevated, increasing financial risk, especially if interest expenses remain high or earnings decline. This leverage magnifies both gains and losses for equity holders.
- Volatile and Choppy Revenue: Sequential quarterly revenue has been inconsistent, moving from $3.20B to $3.15B to $2.89B and back to $3.13B. This choppiness indicates a business susceptible to quarterly fluctuations, complicating growth forecasting.
CCK Technical Analysis
The stock is in a pronounced downtrend and is currently trading near its 52-week lows. With a current price of $95.08, the stock is down 3.48% over the past year and is positioned at approximately 81% of its 52-week range ($89.21 to $116.62), indicating it is much closer to its annual low than its high. This positioning suggests the stock is in a zone of potential value, but also reflects significant negative momentum and market skepticism. Recent momentum has been decisively negative, with the stock declining 3.98% over the past month and a sharp 17.03% over the last three months, diverging significantly from the S&P 500's positive returns of 6.31% and 10.28% over the same periods, as evidenced by relative strength figures of -10.29 and -27.31. This severe underperformance signals strong selling pressure and a lack of positive catalysts. Key technical levels are clearly defined, with immediate support at the 52-week low of $89.21 and resistance near the 52-week high of $116.62. A breakdown below $89.21 would signal a continuation of the bearish trend, while a sustained move above the $100-$105 range is needed to suggest stabilization. The stock's beta of 0.646 indicates it is approximately 35% less volatile than the broader market, which has not shielded it from a significant drawdown of -18.11%.
Beta
0.63
0.63x market volatility
Max Drawdown
-20.7%
Largest decline past year
52-Week Range
$89-$117
Price range past year
Annual Return
-1.0%
Cumulative gain past year
| Period | CCK Return | S&P 500 |
|---|---|---|
| 1m | +6.6% | +1.8% |
| 3m | +3.1% | +15.1% |
| 6m | -0.4% | +9.7% |
| 1y | -1.0% | +25.0% |
| ytd | -2.5% | +9.5% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CCK Fundamental Analysis
Crown's revenue trajectory shows modest growth but with notable volatility in profitability. Q4 2025 revenue was $3.13 billion, representing a 7.72% year-over-year increase from the prior-year quarter. However, sequential quarterly revenue has been choppy, moving from $3.20B in Q3 to $3.15B in Q2, $2.89B in Q1, and back to $3.13B in Q4, indicating a business susceptible to quarterly fluctuations. Profitability has been inconsistent, with Q4 2025 net income of $149 million on a gross margin of 10.3%, a significant compression from the 22.6% gross margin reported in Q2 2025. The net margin for the latest quarter stands at 4.76%, down from 6.68% in Q3. This margin volatility, particularly the sharp drop in Q4 gross margin, suggests pressure from input costs or mix shifts. The balance sheet and cash flow reveal a leveraged but cash-generative operation. The debt-to-equity ratio is elevated at 2.06, indicating significant financial leverage. Positively, the company generated substantial free cash flow of $1.10 billion on a TTM basis and $236 million in the latest quarter. The current ratio of 1.03 suggests adequate but not robust short-term liquidity. Return on equity is strong at 24.47%, but this is amplified by the high leverage, and the return on assets is a more modest 7.24%.
Quarterly Revenue
$3.1B
2025-12
Revenue YoY Growth
+0.07%
YoY Comparison
Gross Margin
+0.10%
Latest Quarter
Free Cash Flow
$1.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CCK Overvalued?
Given a positive net income, the primary valuation metric is the P/E ratio. The trailing P/E stands at 16.16x, while the forward P/E is significantly lower at 10.76x, based on estimated EPS of $9.50. This 33% discount of the forward multiple to the trailing multiple reflects market expectations for a substantial earnings recovery. Compared to sector peers, Crown trades at a discount on a Price-to-Sales basis, with a PS ratio of 0.96x. The EV/EBITDA multiple of 8.50x also appears reasonable for an industrial company. The forward P/E of 10.76x, if earnings estimates are met, suggests the stock is not expensive relative to its own historical earnings power. Historically, the stock's valuation has fluctuated significantly; its current trailing P/E of 16.16x is below the 19.64x seen at the end of Q4 2025 and well below peaks above 35x seen in early 2024, but above the low of 6.85x at the end of 2024. This places the current valuation in the mid-to-lower range of its recent historical band, suggesting the market has already priced in considerable pessimism, particularly regarding margin pressures.
PE
16.2x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -16x~86x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
8.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are significant, centered on extreme margin volatility and high leverage. The Q4 gross margin collapse from 22.6% to 10.3% quarter-over-quarter is a severe red flag, indicating the business may lack pricing power or cost control. An elevated debt-to-equity ratio of 2.06 increases refinancing risk and interest expense burden, which totaled $95M last quarter. Furthermore, choppy sequential revenue—varying by over $300M between quarters—points to earnings visibility issues, making the forward P/E of 10.76x reliant on a stable earnings recovery that is not guaranteed.
Market & Competitive Risks include valuation compression and severe underperformance. Despite a low forward P/E, the stock's 3-month relative strength of -27.31 shows it is being aggressively sold off even as the market rallies. Trading at 81% of its 52-week range, it faces technical selling pressure with each bounce. As a packaging company, it faces competitive pressure and potential demand softness in key regions like Europe and South America. The recent JP Morgan downgrade highlights growing institutional skepticism that could lead to further multiple contraction if margin concerns persist.
Worst-Case Scenario involves a failure to recover gross margins, leading to consecutive earnings misses and a breach of debt covenants. This could trigger analyst downgrades to Sell, a loss of dividend coverage, and a rush for the exit by remaining investors. The realistic downside is to the 52-week low of $89.21, representing a -6.2% decline from $95.08. However, if sentiment deteriorates further and the stock re-tests its historical low P/E of 6.85x on depressed earnings, the decline could exceed -30%. The chain of events would be: Q2 2026 margins remain below 15%, leading to an EPS miss, followed by credit rating scrutiny and accelerated selling.
FAQ
The primary risk is operational: the extreme volatility and recent collapse in gross margin (from 22.6% to 10.3%), which threatens core profitability. Financial risk is also elevated due to high leverage, with a debt-to-equity ratio of 2.06 amplifying downside. Market risk is significant, as the stock has shown severe underperformance (-27% relative strength vs. SPY over 3 months) and could face further selling pressure. Finally, there is sentiment risk, evidenced by a recent analyst downgrade and limited coverage, which could lead to exaggerated moves on negative news.
The 12-month forecast is bifurcated, with a base case target range of $95-$105 (55% probability), a bull case of $110-$116.62 (25%), and a bear case of $82-$89.21 (20%). The most likely scenario is a base case where the stock remains range-bound as margins stabilize but do not fully recover, leading to EPS near $8.80. The key assumption behind this forecast is that the catastrophic Q4 gross margin was partially an anomaly, but structural headwinds prevent a swift return to historical profitability levels above 20%. The outcome hinges almost entirely on the next two quarterly gross margin prints.
CCK appears fairly valued to slightly undervalued based on forward earnings, but the discount is warranted. Its forward P/E of 10.76x is low, especially compared to its own trailing P/E of 16.16x, suggesting the market has priced in earnings growth and margin concerns. The Price-to-Sales ratio of 0.96x is also reasonable. However, this valuation implies the market expects only a partial recovery from the current profitability crisis. Compared to its historical P/E range (from 6.85x to over 35x), the current multiple is in the lower mid-range, indicating the market is paying a cautious, but not distressed, price for the stock.
CCK presents a high-risk, potentially high-reward opportunity for specific investors. At a forward P/E of 10.76x and with strong TTM free cash flow of $1.10B, it appears undervalued. However, the severe gross margin collapse to 10.3% and the stock's position near 52-week lows indicate significant fundamental and technical risk. It could be a good buy for patient, value-oriented investors willing to bet on a margin recovery, but it is not suitable for those seeking stability or short-term gains. The modest 7.5% upside to the average analyst target suggests limited near-term enthusiasm.
CCK is unsuitable for short-term trading due to its low beta (0.65), negative momentum, and lack of near-term catalysts. It is better suited for a long-term (2+ year) investment horizon, allowing time for a potential operational turnaround and margin recovery to materialize. The stock's value proposition and strong cash flow generation are long-term characteristics. However, given the high volatility in fundamentals, investors must be prepared for a bumpy ride. A minimum holding period of 12-18 months is suggested to properly assess whether the margin recovery thesis is playing out.